Bruce C. Cozadd - 31 Aug 2026 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Reporting relationship: Director
Issuer ticker: JAZZ
Reported as of: 31 Aug 2026
Net transaction value: -$1,500,780
SEC form: 4
Accepted by SEC: 02 Sep 2026, 17:03:36 UTC
Prior SEC filing: 07 Aug 2026
Source filing: View source filing
Reporting owner signature: By: /s/Paz Dizon, as attorney in fact For: Bruce C. Cozadd

Key filing fact

Bruce C. Cozadd filed Form 4 for Jazz Pharmaceuticals plc (JAZZ) on 02 Sep 2026.

Key facts

This page summarizes Bruce C. Cozadd's Form 4 filing for Jazz Pharmaceuticals plc (JAZZ).
3 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 02 Sep 2026, 17:03.

Change

Previous filing in this sequence was filed on 07 Aug 2026.
Current net transaction value: -$1,500,780.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001193210 Primary reporting owner

COZADD BRUCE C

Relationship: Director
Address: 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN 4, IRELAND
Signature: By: /s/Paz Dizon, as attorney in fact For: Bruce C. Cozadd
Signature date: 02 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

JAZZ transaction

Ordinary Shares

Tax liability

Transaction value
Shares: -10
Change %: -0%
Price: $244.06^*
Shares after: 359,084
Date: 31 Aug 2026
Ownership: Direct
Footnotes: F1, F2

JAZZ transaction

Ordinary Shares

Tax liability

Transaction value
Shares: -1,209
Change %: -0.34%
Price: $241.39^*
Shares after: 357,875
Date: 31 Aug 2026
Ownership: Direct
Footnotes: F1

JAZZ transaction

Ordinary Shares

Sale

Transaction value: $1,500,780
Shares: -6,000
Change %: -1.7%
Price: $250.13
Shares after: 351,875
Date: 01 Sep 2026
Ownership: Direct
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

Footnote F2

Includes the November 3, 2025 disposition of 3,193 shares for the withholding of restricted stock units by the Issuer to satisfy FICA taxes arising from the Reporting Person being retirement eligible which was previously inadvertently not reported; not an open market transaction.

Footnote F3

This transaction was made pursuant to a plan adopted by the reporting person on November 26, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person.